Check out the Current Events and Calendar Pages.  The IADC is hosting several exciting and educational activities during the month of June! 

Andrew J. Saykin PsyD, Raymond C. Beeler Professor of Radiology and Imaging Sciences was appointed director of the Indiana Alzheimer Disease Center (IADC) in February 2013. The IADC, based at the Indiana University School of Medicine and IU Health Neuroscience Center, is one of 29 centers sponsored by the National Institute on Aging. The IADC was established in 1991 by Professor Bernardino F. Ghetti, the founding director and a pioneering molecular neuropathologist, along with a multidisciplinary group of highly committed colleagues including co-leaders Dr. Hugh C. Hendrie, Emeritus Chairman and Professor of Psychiatry, and P. Michael Conneally, Emeritus Professor of Medical and Molecular Genetics. Dr. Ghetti, Distinguished Professor and Chancellor's Professor of Pathology and Laboratory Medicine, will continue to direct the Neuropathology Core of the IADC which has conducted numerous ground breaking studies of hereditary dementias including Alzheimer disease (AD) and other neurodegenerative conditions.

Dr. Saykin, a neuropsychologist, whose research focuses on using advanced brain imaging and genetics methods to understand disorders affecting memory and cognition, joined the IADC team after being recruited to Indiana from Dartmouth Medical School in late 2006 to lead the IU Center for Neuroimaging. Advances in brain imaging have become increasingly important for early detection of disorders leading to dementia. Therefore, an early priority was to add a Neuroimaging Core to the IADC which was successfully accomplished with a competitive grant in 2009. As the new center director, Dr. Saykin is honored to carry on the longstanding tradition of excellence in dementia research at the IADC toward the goal of one day preventing this devastating disease through early detection and identifying novel therapeutic approaches. He believes that transdisciplinary team science is the key to reaching these goals and looks forward to an expanded scope for the IADC with new collaborators and especially promising junior scientists joining the urgent efforts to address AD and related dementias. He is optimistic about advances in the field of dementia research and excited to have the opportunity to collaborate with the highly accomplished group of core leaders, clinicians and scientists who have made many contributions to research as well as state-of-the-art patient care and family and community education and intervention.